Biomarkers in Chronic Fatigue Syndrome
By Linda on Jun 10, 2010 in F.I.G.H.T., Infections | comments(0)
Full article: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0010817
Excerpt:
Chronic Fatigue Syndrome (CFS) studies from our laboratory and
others described decreased natural killer cell cytotoxicity
(NKCC) and elevated proportion of lymphocytes expressing the
activation marker, dipeptidyl peptidase IV (DPPIV) also known as
CD26. However, neither these assays nor other laboratory tests
are widely accepted for the diagnosis or prognosis of CFS. This
study sought to determine if NKCC or DPPIV/CD26 have diagnostic
accuracy for CFS.
